Perihilar Cholangiocarcinoma (Klatskin Tumor): Diagnosis, Liver Resection, and Multidisciplinary Care
Biliary tract cancers require careful integration of biliary anatomy, vascular relationships at the hepatic hilum, and coordinated multidisciplinary oncologic sequencing. This section reflects a focused hepatopancreatobiliary (HPB) surgical oncology practice dedicated to complex bile duct and gallbladder cancers, including perihilar cholangiocarcinoma, distal cholangiocarcinoma, and gallbladder cancer.
Perihilar Cholangiocarcinoma in the Context of Biliary Anatomy and Liver Surgery
Perihilar cholangiocarcinoma, historically referred to as a Klatskin tumor, arises at the junction of the right and left hepatic bile ducts near the liver hilum. This region represents one of the most anatomically complex areas of hepatobiliary surgery.
Successful treatment requires integration of:
detailed biliary anatomy
vascular relationships at the hepatic hilum
liver function and future liver remnant planning
systemic therapy strategy
advanced hepatopancreatobiliary surgical expertise
As a fellowship-trained robotic surgical oncologist and hepatopancreatobiliary (HPB) surgeon serving the San Francisco Bay Area, Dr. Geoffrey W. Krampitz specializes in complex liver resection and biliary reconstruction for perihilar cholangiocarcinoma within a multidisciplinary cancer program.
Understanding the Liver Hilum
The hepatic hilum is the region where the liver’s major vascular and biliary structures converge.
This area contains:
the right and left hepatic bile ducts
the portal vein and its branches
the hepatic artery and its branches
Perihilar cholangiocarcinoma frequently spreads along bile ducts and may involve adjacent vascular structures, making surgical treatment technically demanding.
Because these tumors often extend along the biliary tree rather than forming discrete masses, careful imaging interpretation and surgical planning are essential.
Symptoms of Perihilar Cholangiocarcinoma
Most patients present with symptoms related to bile duct obstruction.
Common symptoms include:
yellowing of the skin or eyes (jaundice)
dark urine
pale stools
generalized itching (pruritus)
fatigue
cholangitis (infection of the bile ducts)
These symptoms often prompt diagnostic imaging and biliary evaluation.
Evaluation and Diagnosis
Accurate staging is essential to determine surgical candidacy and treatment sequencing.
Imaging
Evaluation typically includes:
MRI with MRCP to evaluate bile duct anatomy
Multiphasic CT scan of the abdomen
CT scan of the chest
MRI with MRCP is particularly valuable in defining:
the extent of bile duct involvement
relationship to portal vein and hepatic artery branches
involvement of the right or left hepatic ducts
Tumor extent is often classified using the Bismuth–Corlette classification, which describes how far the tumor extends into the right and left bile ducts.
Endoscopic and Interventional Procedures
Because many patients present with biliary obstruction, endoscopic or percutaneous procedures may be required.
These may include:
ERCP with biliary stent placement
Percutaneous biliary drainage
tissue sampling when feasible
Selective biliary drainage may help improve liver function prior to surgery.
Laboratory Testing
Laboratory evaluation typically includes:
liver function tests
bilirubin levels
CA 19-9 tumor marker
These findings help guide diagnosis and treatment planning.
Staging and Determining Resectability
Treatment planning depends on careful evaluation of several key factors:
extent of bile duct involvement
portal vein or hepatic artery invasion
distribution of disease within the liver
regional lymph node involvement
functional liver reserve
Unlike many cancers, resectability in perihilar cholangiocarcinoma depends not only on tumor removal but also on whether sufficient healthy liver can remain after surgery.
Future Liver Remnant Planning
Major liver resection is frequently required for perihilar cholangiocarcinoma.
Safe surgery therefore requires preservation of an adequate future liver remnant (FLR).
Advanced hepatobiliary programs use three-dimensional imaging reconstruction and precision volumetric analysis to determine whether sufficient liver will remain after resection.
If the predicted future liver remnant is too small, strategies may be used to stimulate liver growth prior to surgery.
These may include:
portal vein embolization (PVE)
hepatic and portal vein embolization (HPVE) in selected cases
These techniques redirect blood flow to the remaining liver and stimulate hypertrophy before surgery.
Careful preoperative planning helps minimize the risk of postoperative liver failure and allows safe performance of complex hepatectomy.
Surgical Treatment
When tumors are resectable, surgery offers the best opportunity for long-term disease control.
Treatment typically involves combined liver and bile duct resection, including:
removal of the involved bile ducts
partial hepatectomy (often right or left hepatectomy)
regional lymph node dissection
complex biliary reconstruction
Biliary reconstruction usually requires creation of a hepaticojejunostomy, reconnecting the remaining bile ducts to the small intestine to restore bile drainage.
The objective is complete tumor removal with negative margins while preserving adequate liver function.
For additional discussion of liver resection techniques, see Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Liver Transplantation (Selected Patients)
In carefully selected patients with early-stage perihilar cholangiocarcinoma, liver transplantation following specialized pre-transplant therapy may be considered at experienced transplant centers.
These protocols involve strict eligibility criteria and multidisciplinary evaluation.
Systemic Therapy and Molecular Profiling
Systemic therapy may be incorporated into treatment planning depending on tumor stage and resectability.
Chemotherapy may be used:
before surgery in selected patients
after surgery to reduce recurrence risk
as primary treatment in unresectable disease
Molecular profiling is increasingly used to identify potential therapeutic targets, including alterations involving:
FGFR2
IDH1
DNA damage repair pathways
Integration of molecular findings may guide targeted therapy or clinical trial options.
Robotic and Minimally Invasive Surgery
Perihilar cholangiocarcinoma often requires open liver resection due to the complexity of hilar anatomy and need for vascular control.
However, robotic-assisted techniques may play a role in carefully selected cases for portions of liver mobilization or resection.
Surgical approach is determined strictly by oncologic safety and anatomical considerations.
Learn more about advanced techniques in Robotic Surgery.
Risks of Surgery
Potential complications following surgery may include:
bile leak
bleeding
liver dysfunction
infection
These operations require careful perioperative management within experienced hepatopancreatobiliary programs.
Multidisciplinary Care
Management of perihilar cholangiocarcinoma requires close collaboration among:
surgical oncology
hepatology
medical oncology
interventional radiology
radiation oncology
pathology
Treatment sequencing is individualized based on tumor biology, imaging findings, and patient goals.
Conclusion: Specialized Care for Complex Biliary Cancer
Perihilar cholangiocarcinoma is among the most complex cancers treated in hepatopancreatobiliary surgery. Successful treatment requires careful integration of imaging, biliary anatomy, liver surgery planning, and multidisciplinary cancer care.
In carefully selected patients, combined liver resection and bile duct reconstruction offers the best opportunity for long-term disease control.
Consultation and Referral
For Patients:
Individuals seeking evaluation for bile duct cancers — including perihilar cholangiocarcinoma — may Request a Consultation to discuss individualized treatment strategies.
For Referring Physicians:
Physicians wishing to refer a patient or discuss complex biliary tumors may visit For Physicians for coordinated referral pathways and case review.